DEALS: Qiagen buys key assets
Qiagen buys key assets
|
DEALS |
|||
|
WHO |
WITH |
WHAT |
SCOOP |
|
Altana |
Eckhart |
$768 million buyout |
Once the deal is complete, Altana will add Eckhart's chemicals and pigments unit to its chemicals division and spin the venture off as a separate company. |
|
Qiagen |
SuNyx |
asset buyout |
Qiagen buys technology that examines sample preparation by leveraging unique, nanotechnology-based surface structures. |
|
Qiagen |
LumiCyte |
asset buyout |
LumiCyte has been developing capability that dramatically increases the limits of detection achievable through mass spectroscopy. |
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
